Status: Bibliographieeintrag
Standort: ---
Exemplare:
---
| |  Online-Ressource |
|---|
| Verfasst von: | Wanner, Christoph [VerfasserIn]  |
|---|
| | Krane, Vera [VerfasserIn] |
|---|
| | Ruf, Günther [VerfasserIn] |
|---|
| | März, Winfried [VerfasserIn] |
|---|
| | Ritz, Eberhard [VerfasserIn] |
|---|
| Titel: | Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis |
|---|
| Verf.angabe: | Christoph Wanner, Vera Krane, Günther Ruf, Winfried März, and Eberhard Ritz |
|---|
| E-Jahr: | 1999 |
|---|
| Jahr: | 1 July 1999 |
|---|
| Umfang: | 5 S. |
|---|
| Fussnoten: | Gesehen am 28.10.2021 |
|---|
| Titel Quelle: | Enthalten in: Kidney international |
|---|
| Ort Quelle: | New York, NY : Elsevier, 1972 |
|---|
| Jahr Quelle: | 1999 |
|---|
| Band/Heft Quelle: | 56(1999), Suppl. 71, Seite S222-S226 |
|---|
| ISSN Quelle: | 1523-1755 |
|---|
| Abstract: | Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. - Background - Non-insulin-dependent diabetes mellitus dialysis patients have the highest cardiovascular mortality known in any group of patients. Mixed dyslipidemia with moderately elevated low-density lipoprotein (LDL) cholesterol and high levels of triglyceride-rich lipoproteins is common in this condition. It is not known, however, whether patients with type 2 diabetes on dialysis with this form of dyslipidemia derive benefit from lipid-lowering therapy. Recently, drugs have become available that potently lower triglyceride-rich, apoB-containing lipoproteins and thus permit testing of this issue. This is the first trial to address specifically the issue of whether the excessive cardiovascular mortality of patients with type 2 diabetes on dialysis can be lowered by statins. |
|---|
| DOI: | doi:10.1046/j.1523-1755.1999.07158.x |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.1046/j.1523-1755.1999.07158.x |
|---|
| | Volltext: https://www.sciencedirect.com/science/article/pii/S0085253815466463 |
|---|
| | DOI: https://doi.org/10.1046/j.1523-1755.1999.07158.x |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | atorvastatin |
|---|
| | cholesterol |
|---|
| | diabetes |
|---|
| | triglycerides |
|---|
| K10plus-PPN: | 1775658090 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis / Wanner, Christoph [VerfasserIn]; 1 July 1999 (Online-Ressource)
68794688
